NAACCR Item #3930: Serum Albumin Pretreatment Level
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3930 | 1 | NAACCR | 2018 | 18 |
NAACCR XML:
Tumor.serumAlbuminPretreatmentLevel
Description
Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a prognostic factor for plasma cell myeloma.
Rationale
Serum albumin pretreatment level is a prognostic factor required in AJCC 8th edition, Chapter 82 *Plasma Cell Myeloma and Plasma Cell Disorders*, for the Revised International Staging System (RISS).
Codes
| 0 | Serum albumin <3.5 g/dL |
| 1 | Serum albumin =3.5 g/dL |
| 5 | Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 |
| 7 | Test ordered, results not in chart |
| 9 | Not documented in medical record Serum Albumin Pretreatment Level not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.